Reaction

Juvenile Idiopathic Arthritis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,418 reports · 61 co-occurring drugs

As of the last recalculation, Juvenile Idiopathic Arthritis appears in 2,418 FAERS reports alongside 61 co-occurring drug terms. The strongest observed disproportionality signal is ANAKINRA (PRR 227.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Anakinra	371	227.2	232.4
Canakinumab	154	130.8	132.7
Adalimumab-Fkjp	451	102.8	103.8
Adalimumab-Aaty	449	100.1	101.0
Adalimumab-Adaz	459	92.2	93.0
Tocilizumab	604	60.4	60.7
Triamcinolone Acetonide Ointment Usp, 0.05%	143	55.8	56.2
Sulfasalazine	384	50.0	50.3
Naproxen Sodium Tablet, Coated	74	48.5	48.8
Naproxen Sodium, Coated Tablets	74	48.5	48.8
Naproxen Sodium 220Mg	74	48.4	48.7
Dimenhydrinate	55	45.4	45.7
Triamcinolone Acetonide	143	42.3	42.5
Naproxen	325	41.0	41.2
Bisacodyl Suppositories	54	36.7	36.9
Biscodyl	54	36.4	36.5
Abatacept	473	36.3	36.4
Bisacodyl	55	34.4	34.5
Phenobarbital	55	33.4	33.5
Hydroxychloroquine	251	32.2	32.3
Human Immunoglobulin G	70	30.0	30.1
Methotrexate Sodium	963	27.7	27.7
Hydroxychloroquine Sulfate	262	27.6	27.7
Methotrexate	862	26.8	26.9
Naproxen Sodium	359	25.2	25.3
Infliximab	509	25.1	25.2
Methocarbamol Tablets	42	22.0	22.0
Tofacitinib Citrate	32	21.3	21.3
Etanercept	910	20.4	20.4
Clobazam	56	20.2	20.2
Methocarbamol	44	17.0	17.0
Adalimumab	904	17.0	17.0
Instalax Polyethylene Glycol 3350	23	16.1	16.1
Polyethylene Glycol 400	23	15.8	15.8
Leflunomide	148	12.9	12.9
Aripiprazole Oral	56	11.9	11.9
Aripiprazole Orally Disintegrating	56	11.9	11.9
Golimumab	102	10.6	10.7
Methadone	51	10.5	10.5
Melatonin	61	9.9	9.9
Clonidine	56	9.6	9.6
Certolizumab Pegol	124	9.5	9.6
Prednisone	460	9.5	9.5
Diphenhydramine	62	8.6	8.6
Indomethacin	13	8.5	8.5
Folic Acid	217	8.1	8.1
Celecoxib	110	7.5	7.5
Fluticasone Furoate	10	7.1	7.1
Fluoxetine	46	6.0	6.0
Montelukast	57	6.0	6.0
Baclofen	58	5.9	5.9
Busulfan	10	5.5	5.5
Leuprolide Acetate	48	5.4	5.4
Tofacitinib	107	5.2	5.2
Fesoterodine Fumarate	6	4.8	4.8
Sarilumab	14	4.6	4.6
Baricitinib	5	4.5	4.5
Methadone Hydrochloride	5	4.0	4.0
Ranitidine	68	3.0	3.0
Somatropin	19	2.2	2.2
Ranitidine Hydrochloride	12	1.9	1.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.